News & Updates
Showing Multidisciplinary articles
Showing
Show Multimedia Only

Ensifentrine improves lung function, cuts exacerbations in COPD
04 Dec 2023
byAudrey Abella
The novel, selective, dual PDE*3 and PDE4 inhibitor ensifentrine improved lung function and reduced exacerbations in individuals with chronic obstructive pulmonary disease (COPD), findings from the ENHANCE**-1 and ENHANCE-2 trials have shown.
04 Dec 2023

Gastrointestinal issues linger long after COVID-19 recovery
04 Dec 2023
Gut-brain interaction disorders and persistent gastrointestinal (GI) symptoms prevail 12–18 months following COVID-19 hospitalization, and these prolonged GI issues are associated with the severity of the symptoms during hospitalization and the psychological toll of the illness experience, according to a study.
04 Dec 2023







